Esophageal Adenocarcinoma Methods and Protocols

293

References

1. Cahill DJ (2001) Protein and antibody arrays
   and their medical applications. J Immunol
   Methods 250:81–91


2. Plebani M (2005) Proteomics: the next revolu-
   tion in laboratory medicine? Clin Chim Acta
   357:13–22


3. Colantonio DA, Chan DW (2005) The clinical
   application of proteomics. Clin Chim Acta
   357:151–158


4. Hu L, Ye M, Jiang X, Feng S, Zhou H et al
   (2007) Advances in hyphenated analytical tech-
   niques for shotgun proteome and peptidome
   analysis—a review. Anal Chim Acta
   598:193–204


5. Pastwa E, Somiari SB, Czyz M, Somiari R
   (2007) Proteomics in human cancer research.
   Proteomics Clin Appl 1:4–17


6. Soldes OS, Kuick RD, Thompson IA, Hughes
   SJ, Orriger MB, Lannettoni MD, Hanash SM,
   Beer DG (1999) Differential expression of
   Hsp27 in normal oesophagus, Barrett’s meta-
   plasia and esophageal adenocarcinomas. Br
   J Cancer 79:595–603


7. Paweletz CP, Ornstein DK, Roth MJ, Bichsel
   VE, Gillespie JW, Calvert VS et al (2000) Loss
   of annexin 1 correlates with early onset of
   tumorigenesis in esophageal and prostate carci-
   noma. Cancer Res 60:6293–6297


8. Hayashida Y, Honda K, Osaka Y, Hara T,
   Umaki T, Tsuchida A et al (2005) Possible pre-
   diction of chemoradiosensitivity of esophageal

cancer by serum protein profiling. Clin Cancer

Res 11:8042–8047

9. Kelly P, Appleyard V, Murray K, Paulin F,
   Lamont D, Baker L et al (2010) Detection of
   esophageal cancer biomarkers by plasma pro-
   teomic profiling of human cell line xenografts
   in response to chemotherapy. Br J Cancer
   103:232–238


10. Kelly P, Paulin F, Lamont D, Baker L, Clearly S,
    Exon D, Thompson A (2012) Pre-treatment
    plasma proteomic markers associated with survival
    in esophageal cancer. Br J Cancer 106:955–961


11. Hortin GL, Sviridov D, Anderson NL (2008)
    High-abundance polypeptides of the human
    plasma proteome comprising the top 4 logs of
    polypetide abundance. Clin Chem
    54:1608–1616


12. Zolotarjova N, Martosella J, Nicol G, Bailey J,
    Boyes BE, Barrett WC (2005) Differences
    among techniques for high-abundance protein
    depletion. Proteomics 5:3304–3313


13. Granger J, Siddiqui J, Copeland S, Remick D
    (2005) Albumin depletion of human plasma
    also removes low abundance proteins including
    the cytokines. Proteomics 5:4713–4718


14. Pappin DJ, Hojrup P, Bleasby AJ (1993) Rapid
    identification of proteins by peptide-mass fin-
    gerprinting. Curr Biol 3:327–332


15. Mascot Server (2016) Matrix Science, London.
    http://www.matrixscience.com. Accessed 15
    Jan 2017

Proteomic Protocol